The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
about
Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cellsAdvances in the treatment of metastatic melanoma: adoptive T-cell therapyCancer biomarker discovery: the entropic hallmark.ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expressionELR+ CXC chemokine expression in benign and malignant colorectal conditionsStimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate.An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.7-Ketocholesterol induces inflammation and angiogenesis in vivo: a novel rat model.Role of CXCL1 in tumorigenesis of melanoma.Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growthCiglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male miceFine tuning the transcriptional regulation of the CXCL1 chemokineTumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.Role of infiltrated leucocytes in tumour growth and spread.Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.GROα regulates human embryonic stem cell self-renewal or adoption of a neuronal fate.Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.Temporal phenotypic features distinguish polarized macrophages in vitroTherapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokinesModulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasisElevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model.Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.MGSA/GRO-mediated melanocyte transformation involves induction of Ras expressionObesity as a major risk factor for cancer.Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathwayProstaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaChemokines and the microenvironment in neuroectodermal tumor-host interactionThe good and the bad of chemokines/chemokine receptors in melanoma.Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14.Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway.BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation.IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.
P2860
Q21245718-E1A524F8-B60B-46C5-BF34-91417CAFDAB7Q27027803-A1E48D19-EC0D-4580-85B0-3E30B406C371Q30496149-DC913834-57CE-4D0A-A093-1FF44A66D696Q30811602-A592F754-4D20-463D-B395-8639A420E16DQ33346619-AE1FA616-9DB6-4F7E-9D77-4CCD23C7F06FQ33634686-D7D51F24-D4A8-4F60-AD7C-7DB7290246A6Q33769541-413B0162-3B4D-421E-AABF-799C2F626717Q34028872-36D9F51D-9E78-4FCE-A0C4-F8B06562BF44Q34065213-7B694BB4-B371-4532-9EFB-241CB6B44E6CQ34268435-FC7755E9-9ED2-4CF2-AAFC-BE063196C146Q34586643-91E98012-B474-4778-9310-E531FD5F1CCEQ34724089-765D3F90-5D23-4744-827C-6203DF1DFE52Q34811043-DB7C131E-BD33-4C13-AC44-94400CD53F93Q35092571-93179FB7-39BB-41B5-9F72-D23196546542Q35133880-12177850-5D56-4C09-B2D3-8357371917E2Q35199750-3B1E4E24-124A-4156-9A3C-03D7D5E9DB34Q35543779-6164C0ED-821A-4C8F-8C81-92C1F6614EF5Q35746831-F6F0FB74-2CE6-468A-A32A-0553151988DAQ35784552-46C1AA45-517E-4785-8515-C3357F89F597Q35784652-471F7244-3C57-41C7-9722-78B2EA9DB4D9Q36018997-25769C4C-B5F0-4B2E-A77B-B362A18C1F6AQ36084010-4E6A24CF-177E-4994-A4BA-CFE809C0A3B8Q36377797-139EDA77-9ACA-45D9-8E3D-36C5FBD09151Q36389337-D0EFB54F-2AA8-4130-9F52-C54875136187Q36530744-4EE9CE20-B6BD-4809-A8D2-B91400CFF7ABQ36615128-93A92698-FDA9-40D5-8075-F539B0009C78Q37149860-477D8F52-0CBB-4DA7-8A6F-10C60E2A822BQ37154670-CCFAF17D-F651-4DEA-98B5-706CFF518CAEQ37171959-CE1B94AE-9A41-4135-9849-E1B1D0595972Q37177311-46FFF297-91FA-4974-8E38-7C3942CBECE6Q37266333-784A98A1-B0D5-4952-AE43-7E5B07D4BE72Q37339444-A6E14FA9-7DB3-4B39-8C9C-5F27325E7491Q37394981-D6D714EE-C72E-4883-A92D-62C52297A32DQ37641789-3E7DCC3B-CE72-427B-BFD0-4DD2188DA0F2Q38994985-EE9F1DB6-1E0A-4D58-A483-780DCD686A96Q40152334-13212B5D-996F-4485-B29C-8DD2492AA072Q40318894-BA179A5C-6931-4348-9CEB-3B40A36D7977Q40956900-E0F75C09-D30A-4BEE-8EF7-99AC840E9C6BQ41109128-CB95141D-24A2-4AD2-8BC5-ED9B5289D42EQ41975379-2D05C654-C33B-4069-AF89-1CB6F977B69F
P2860
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@ast
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@en
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@nl
type
label
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@ast
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@en
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@nl
prefLabel
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@ast
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@en
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@nl
P2093
P2860
P3181
P1476
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
@en
P2093
A Richmond
H Haghnegahdar
L B Nanney
M D Burdick
N Cardwell
R M Strieter
R Shattuck-Brandt
P2860
P3181
P407
P577
2000-01-01T00:00:00Z